Beranda › Miastenia Gravis › Tennessee › Chattanooga
Uji klinis Miastenia Gravis di Chattanooga, TN
6 studi untuk Miastenia Gravis mencari peserta di lokasi sekitar Chattanooga (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
Menerima pesertaFase 2
- Erlanger Health System, Chattanooga
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Menerima pesertaStudi observasional
- Erlanger Health System, Chattanooga
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Menerima pesertaFase 2
- Erlanger Health System, Chattanooga
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Menerima pesertaFase 3
- Erlanger Health, Inc. - 1123255, Chattanooga
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Menerima pesertaFase 2
- Ut Erlanger Neurology, Chattanooga
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Menerima pesertaStudi observasional
- Clinical Trial Site, Chattanooga
Uji klinis Miastenia Gravis di kota lain
- Tampa, FL12 studi
- Houston, TX11 studi
- Durham, NC10 studi
- Boca Raton, FL10 studi
- Columbus, OH8 studi
- Miami, FL7 studi
- New York City, NY7 studi
- Milwaukee, WI7 studi
- St. Louis, MO7 studi
- Boston, MA6 studi
- Washington, DC6 studi
- San Francisco, CA6 studi
Studi lain di Chattanooga
- Kanker Paru Non-Sel Kecil11 studi
- Kanker Metastatik6 studi
- Kanker Ovarium5 studi
- Diabetes4 studi
- Penyakit Hati Steatotik4 studi
- Melanoma4 studi
- Stroke Iskemia4 studi
- Kanker Kolorektal4 studi
- Penyakit Ginjal Kronis4 studi
- Kanker Paru4 studi
- Gagal Ginjal3 studi
- Aterosklerosis3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.